Tuesday, November 30, 2021

Business Intelligence Monitor 211201

(Introduction)

[Markets]


[Indicators]
•   US Sep. Case–Shiller home price: U.S. Home-Price Growth Decelerated in September
※   Conference Board index declines to 109.5 from 111.6 in October
•   US Weekly Oil Inventories(EIA): Cushing Crude Inventories Are Rising As Oil Prices Fall
※   Anxiety grows over central bank policies as consumer prices continue to rise
※   Non-manufacturing index slows slightly on weaker services
•   Japan Oct. Industrial production: Japan's Oct. industrial output rises 1.1% on month
•   India Oct. Core industry production: Eight core sectors' output grows to 7.5% in October
•   한국 10월 사업체노동력: 임금상승률 반토막···임시일용직의 눈물


[Trackers]
•   Johns Hopkins University: COVID-19 Global Cases & Deaths
•   Worldometer: COVID Live Update
•   Bloomberg: Covid-19 Vaccine Tracker
•   Bloomberg: Global PMI Tracker
•   Bloomberg: The Covid Resilience Ranking


[News]
※   ‘The risk of higher inflation has increased,’ the Fed chairman tells lawmakers
※   Latest virus strain could slow global growth but any hit is likely to be modest, economists say
※   Some scientists say the virus will likely remain vulnerable to immune cells; ‘Don’t freak out,’ says BioNTech co-founder
※   Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant
※   Endorsement of molnupiravir, from Merck and partner Ridgeback, could open the door for FDA authorization before the end of the year
※   Experts caution, though, that the variant could have originated elsewhere.
※   New hypersonic missiles will enter service next year, says Russian president
※   Anti-immigration polemicist laments decadence and says people feel like strangers in their own country
※   The agency is looking measures such as narrowing the testing window for travelers into the country and adding quarantine requirements in certain cases
※   Incoming vice chancellor backs proposal for tougher curbs
※   Japan confirmed its first case of omicron variant as the nation closed its borders to new foreign entrants
※   "No one is happy when inflation is running at 4% or 5% when our goal is 2%,"
※   내년 초 완료 예정인 유상증자를 포함해 두산중공업이 진행하고 있는 재무구조 개선 결과가 계획대로 원활히 이루어질 경우, MOU 종결에 대해 외부기관의 재무진단을 거쳐 종합적으로 검토할 것


[Opinions]
•   Project Syndicate(Howard Davies): The Sustainability Standards Battle
•   Project Syndicate(Kemal Derviş): Europe's Two Peace Missions
•   Project Syndicate(Andrew Sheng, Xiao Geng): Building a One-Earth Balance Sheet
•   Project Syndicate(Otmar Issing): The High Stakes of Rising Inflation
•   FT(Robert Armstrong): Could the US follow Austria on Covid?
•   WSJ(Editorial Board): The Omicron Non-Emergency
•   WSJ(Editorial Board): Biden Joins the Lumber Trade Wars
•   WSJ(Editorial Board): The Erdogan Lira Crisis
•   WSJ(Walter Russell Mead): Global Free Trade Is in Crisis
•   WSJ(DJ Nordquist, Dan Katz): Where Did That IMF Covid Money Go?
•   NYT(Paul Krugman): What Europe Can Teach Us About Jobs
•   Bloomberg(Brian Chappatta): Markets Race to Process Latest ‘Powell Pivot’
•   Bloomberg(Jonathan Bernstein): How Democrats Learned to Expect the Worst

Monday, November 29, 2021

Business Intelligence Monitor 211130

(Introduction)

[Markets]


[Indicators]
•   US Nov. Dallas Fed manufacturing Index: Texas Manufacturers Are Boosting Wages as Inflation Pressures Rise
•   Eurozone Nov. Economic sentiment: Euro-Area Economic Confidence Retreats as Consumer Mood Slips
•   Vietnam Nov. Balance of trade: Vietnam Sees Surge in Nov. Exports After End of Lockdowns


[Trackers]
•   Johns Hopkins University: COVID-19 Global Cases & Deaths
•   Worldometer: COVID Live Update
•   Bloomberg: Covid-19 Vaccine Tracker
•   Bloomberg: Global PMI Tracker
•   Bloomberg: The Covid Resilience Ranking


[News]
※   New York City broadens mask advisory, reflecting potential risks posed by new variant
※   President Biden said Monday that his administration was working with officials at Pfizer Inc., Moderna Inc. and Johnson & Johnson to develop contingency plans for vaccines or boosters
※   “This variant is a cause for concern, not a cause for panic,” he said.
※   Testing just started, but drugmakers have expressed concern that Covid-19 vaccines won’t work as well against the new strain
※   Negotiations in Vienna aim to address steps Iran and the U.S. will take to revive the 2015 nuclear deal
※   Mutations can work together to make a virus more fearsome, but they can also cancel one another out. This phenomenon, called epistasis, is why scientists are reluctant to speculate on Omicron.
※   While wind and solar ramp up, several countries, including France and Britain, are looking to expand their nuclear energy programs. Germany and others aren’t so enthusiastic.
※   “The likelihood of potential further spread of Omicron at the global level is high,”
※   Initial assessment based on growing ability of economies worldwide to adapt to Covid waves
※   Brussels wants Global Gateway proposals to help boost its influence worldwide
※   Senate testimony doesn’t discuss tapering of bond purchases
※   The cost of producing green hydrogen with renewable energy is set to fall and the capacity to produce it in Europe and nearby countries will likely surpass current targets by 2030
※   “This is a tool that was available to us and will be available again,”
※   Moderna CEO Stephane Bancel told CNBC that it could take months to develop and ship an omicron specific vaccine, but a higher dose of its booster could be ready much sooner.
※   Industry tries to buy time for fossil fuel plants as pressure to go green mounts


[Opinions]
•   Project Syndicate(Helmut K. Anheier): A More Daring Germany
•   Project Syndicate(Nina L. Khrushcheva): Send Out the Clowns
•   Project Syndicate(Jean Pisani-Ferry): The End of the Economic Consensus
•   Project Syndicate(Hans-Werner Sinn): The End of Free Money
•   FT(Editorial Board): The gap between US spending and confidence
•   FT(Gideon Rachman): Why China’s elite tread a perilous path
•   FT(Robin Wigglesworth): Markets are more fragile than investors think
•   FT(Robert Armstrong): Why junk bond yields are not so absurd
•   FT(Robert Armstrong): Is Omicron different for markets?
•   FT(Mary O'Sullivan): The economic lure of alternative worlds
•   FT(Claire Jones): Is a BoE rate hike off the cards?
•   FT(Jamie Powell): China’s population is shrinking, fast
•   WSJ(James Freeman): Biden’s Partisan Pandemic History
•   WSJ(Thomas J. Duesterberg): The WTO’s Fast Track to Irrelevance
•   Bloomberg(Bobby Ghosh): Iran Shows It Isn’t Serious About Nuclear Talks
•   Nikkei Asia(Peter A. Petri, Michael G. Plummer): Why South Korea should join the CPTPP